Third, data on the predictive role of PIK3CA-mut/gain to alpelisib from BC and pan-cancer cells and PDX are not univocal and data from patients treated with alpelisib derive from very limited and non-randomized cohorts. This evidence concerns the gene PIK3CA and breast cancer.